5 Fanconi Anemia Clinical Trials in Loma Linda, CA (2026)

Q: How do I join a clinical trial in Loma Linda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you.

Recruiting Fanconi Anemia Studies in Loma Linda

NCT05685745Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveri...

Loma Linda, CA5,000 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT06736574Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in p...

Loma Linda, CA1,800 participantsCytokinetics

View Study Details

NCT06378632Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively ...

Loma Linda, CA500 participantsCordio Medical

View Study Details

NCT05446272Recruiting

The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial

DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 23 0/7-28 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasi...

Loma Linda, CA478 participantsUniversity of Pennsylvania

View Study Details

NCT06317662Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a KMT2A gene rearrangem...

Loma Linda, CA153 participantsNational Cancer Institute (NCI)

View Study Details

About Fanconi Anemia Clinical Trials in Loma Linda

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 5 fanconi anemia clinical trials recruiting participants in Loma Linda, CA. These studies are seeking a combined 7,931 participants. Research is being sponsored by The University of Texas Health Science Center, Houston, Cytokinetics, Cordio Medical and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Loma Linda — FAQ

Are there fanconi anemia clinical trials in Loma Linda?

Yes, there are 5 fanconi anemia clinical trials currently recruiting in Loma Linda, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 5 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov